Delix Therapeutics presented data for their novel neuroplastogen zalsupindole (DLX-001) at the 2026 American Society of Clinical Neuropharmacology (ASCP) Conference including NeuLogiq Platform ...

Vigil Neuroscience, Inc. has announced its financial results for Q1 2025 and provided updates on its clinical trials. The company is on track to report the final analysis from its Phase 2 IGNITE trial ...

By M. Marin OTCQB: AINMF READ THE FULL AINMF RESEARCH REPORT AINMF believes platform is well-positioned, as use of AI in clinical development is expected to rise NetraMark (OTCQB: AINMF), an AI ...

The 1990s were declared the "Decade of the Brain"—yet, 25 years later, much about the brain remains a mystery. Our brain is the most protected and least accessible organ in the human body, making real ...

– Convergent clinical and preclinical evidence supports the mechanistic link between ALTO-300 and the biomarker, a measure of greater EEG irregularity, being used for patient selection – – Completed ...

Neuroscience is a vast field of study containing a range of narrower subfields. Each involves a spotlight on the brain and other parts of the nervous system, connecting them to one or more zones of ...

JUPITER, FL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company focused on neuroinflammation and central ...

What makes us think the way we do? How do our brains influence our behavior and vice versa? You can help answer these questions and more when you study the neurobiology of behavior. Discover the ...

Cyberpunk: Edgerunners Season 2 neuroscience — the show’s core tragedy maps onto three documented brain-computer interface ...

Brenna Swanston is an education-focused editor and writer with a particular interest in education equity and alternative educational paths. As a newswriter in her early career, Brenna's education ...